Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

NYSE:NVST - New York Stock Exchange, Inc. - US29415F1049 - Common Stock - Currency: USD

19.67  -0.72 (-3.53%)

After market: 19.67 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NVST. NVST was compared to 187 industry peers in the Health Care Equipment & Supplies industry. NVST has only an average score on both its financial health and profitability. NVST has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NVST had positive earnings in the past year.
NVST had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NVST reported negative net income in multiple years.
In the past 5 years NVST always reported a positive cash flow from operatings.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NVST has a Return On Assets of -20.57%. This is comparable to the rest of the industry: NVST outperforms 48.66% of its industry peers.
NVST has a Return On Equity of -37.03%. This is comparable to the rest of the industry: NVST outperforms 51.87% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.59%, NVST is in the better half of the industry, outperforming 70.05% of the companies in the same industry.
NVST had an Average Return On Invested Capital over the past 3 years of 4.17%. This is below the industry average of 7.89%.
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROIC 2.59%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Operating Margin of NVST (6.01%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of NVST has declined.
NVST has a Gross Margin (54.77%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NVST has remained more or less at the same level.
Industry RankSector Rank
OM 6.01%
PM (TTM) N/A
GM 54.77%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

NVST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NVST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NVST has been increased compared to 5 years ago.
The debt/assets ratio for NVST is higher compared to a year ago.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that NVST is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.47, NVST is in line with its industry, outperforming 54.01% of the companies in the same industry.
NVST has a debt to FCF ratio of 5.27. This is a neutral value as NVST would need 5.27 years to pay back of all of its debts.
NVST's Debt to FCF ratio of 5.27 is amongst the best of the industry. NVST outperforms 81.82% of its industry peers.
NVST has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
NVST has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: NVST outperforms 44.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Altman-Z 1.47
ROIC/WACC0.36
WACC7.16%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.12. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
NVST's Current ratio of 2.12 is on the low side compared to the rest of the industry. NVST is outperformed by 63.10% of its industry peers.
NVST has a Quick Ratio of 1.82. This is a normal value and indicates that NVST is financially healthy and should not expect problems in meeting its short term obligations.
NVST has a Quick ratio (1.82) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.82
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NVST have decreased strongly by -49.65% in the last year.
The earnings per share for NVST have been decreasing by -28.29% on average. This is quite bad
Looking at the last year, NVST shows a decrease in Revenue. The Revenue has decreased by -2.30% in the last year.
The Revenue has been growing slightly by 1.90% on average over the past years.
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%

3.2 Future

NVST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.46% yearly.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y40.2%
EPS Next 2Y29.16%
EPS Next 3Y23.71%
EPS Next 5Y33.46%
Revenue Next Year1.68%
Revenue Next 2Y2.46%
Revenue Next 3Y2.61%
Revenue Next 5Y7.74%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.70, NVST can be considered very expensive at the moment.
Based on the Price/Earnings ratio, NVST is valued a bit cheaper than 77.54% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.29, NVST is valued at the same level.
NVST is valuated correctly with a Price/Forward Earnings ratio of 16.15.
Based on the Price/Forward Earnings ratio, NVST is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NVST to the average of the S&P500 Index (21.74), we can say NVST is valued slightly cheaper.
Industry RankSector Rank
PE 27.7
Fwd PE 16.15
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 80.75% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, NVST is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.45
EV/EBITDA 13.62
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

NVST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NVST's earnings are expected to grow with 23.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y29.16%
EPS Next 3Y23.71%

More info and screens

0

5. Dividend

5.1 Amount

NVST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVISTA HOLDINGS CORP

NYSE:NVST (7/7/2025, 8:04:00 PM)

After market: 19.67 0 (0%)

19.67

-0.72 (-3.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners117.29%
Inst Owner Change-0.02%
Ins Owners0.45%
Ins Owner Change10.08%
Market Cap3.33B
Analysts73
Price Target19.61 (-0.31%)
Short Float %6.03%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.98%
Min EPS beat(2)7.34%
Max EPS beat(2)14.62%
EPS beat(4)3
Avg EPS beat(4)-2.03%
Min EPS beat(4)-59.95%
Max EPS beat(4)29.88%
EPS beat(8)4
Avg EPS beat(8)-6.11%
EPS beat(12)6
Avg EPS beat(12)-4.55%
EPS beat(16)10
Avg EPS beat(16)-1.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.58%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-2.02%
Revenue beat(12)0
Avg Revenue beat(12)-2.08%
Revenue beat(16)1
Avg Revenue beat(16)-2.89%
PT rev (1m)-1.17%
PT rev (3m)-10.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 27.7
Fwd PE 16.15
P/S 1.33
P/FCF 12.45
P/OCF 11.24
P/B 1.1
P/tB 40.41
EV/EBITDA 13.62
EPS(TTM)0.71
EY3.61%
EPS(NY)1.22
Fwd EY6.19%
FCF(TTM)1.58
FCFY8.03%
OCF(TTM)1.75
OCFY8.89%
SpS14.77
BVpS17.91
TBVpS0.49
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROCE 3.27%
ROIC 2.59%
ROICexc 3.38%
ROICexgc 21.13%
OM 6.01%
PM (TTM) N/A
GM 54.77%
FCFM 10.7%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Debt/EBITDA 4.81
Cap/Depr 24.14%
Cap/Sales 1.15%
Interest Coverage 2.93
Cash Conversion 110.1%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.82
Altman-Z 1.47
F-Score4
WACC7.16%
ROIC/WACC0.36
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next Y40.2%
EPS Next 2Y29.16%
EPS Next 3Y23.71%
EPS Next 5Y33.46%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%
Revenue Next Year1.68%
Revenue Next 2Y2.46%
Revenue Next 3Y2.61%
Revenue Next 5Y7.74%
EBIT growth 1Y-50.44%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year46.17%
EBIT Next 3Y19.09%
EBIT Next 5Y29.05%
FCF growth 1Y145.91%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y62.64%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%